Insights into the Management of Overactive Bladder: What Difference Can Mirabegron Make?
Journal Title: Journal of Urological Surgery - Year 2019, Vol 6, Issue 2
Abstract
Oral pharmacotherapy constitutes second-line treatment for overactive bladder (OAB) after lifestyle modifications, bladder retraining, and pelvic floor muscle exercises. Antimuscarinics have an established role in the treatment of OAB. However, antimuscarinics are known to have low persistence rates in clinical practice. Mirabegron is an oral β3-adrenoreceptor agonist which has emerged as an alternative to antimuscarinics for managing OAB. Overall, mirabegron has similar clinical efficacy to antimuscarinics and is superior to placebo. Mirabegron has been generally well tolerated in both interventional and non-interventional studies. Persistence has been shown to be higher with mirabegron than with antimuscarinics in realworld studies. Increased blood pressure is associated with mirabegron and therefore its use is contraindicated in patients with severe uncontrolled hypertension. However, a low rate of treatment cessation due to cardiovascular issues has been noted in clinical trials. Mirabegron’s utility in the elderly patient population has been well supported with promising efficacy and safety outcomes. New data from a prospective placebo-controlled randomized trial in older OAB patients is expected to be published soon. Mirabegron does not interfere with detrusor contractions during the emptying phase of the micturition cycle and hence lacks any significant effect on post-void residual volume. Mirabegron can be combined with antimuscarinics to synergize clinical effectiveness. Overall, mirabegron represents a well-tolerated and effective medical treatment option for OAB. Mirabegron could be used as an alternative to antimuscarinics, especially in patients who do not improve with antimuscarinics and/or experience bothersome side effects for whom anticholinergic load may be a relevant consideration.
Authors and Affiliations
Ömer Acar, Mustafa Levent Erton, Tufan Tarcan
Keywords
Related Articles
- EP ID EP48971
- DOI 10.4274/jus.galenos.2019.2533
- Views 359
- Downloads 0
Comparison of 99mTc-DMSA, 99mTc-DTPA and 99mTc-MAG3 Renal Scintigraphy in the Calculation of Relative Renal Function
Objective: The aim of this study was to compare Tc-99m dimercaptosuccinic acid (99mTc-DMSA) renal cortical scintigraphy and Tc-99m diethylene triamine pentaacetic acid (99mTc-DTPA) and Tc-99m mercaptoacetyltriglycine (99...
Comparison of Stone Scoring Systems in Predicting Outcomes of Percutaneous Nephrolithotomy in Patients with Solitary Kidney
Objective: To assess efficacy of the Guy’s Stone score (GSS) and Clinical Research Office of the Endourological Society (CROES) nomogram in predicting outcomes of percutaneous nephrolithotomy (PCNL) in patients with soli...
Can Neutrophil Count, Lymhocyte Count and Neutrophil-tolymphocyte Ratio Predict Fever Following Percutaneous Nephrolithotomy in Patients Without Risk Factors?
Objective: To examine the relationship of neutrophil counts, lymphocyte count and neutrophil-to-lymphocyte ratio (NLR) with postoperative fever in patients undergoing percutaneous nephrolithotomy (PCNL). Materials and M...
Microsurgical Varicocele Ligation: Surgical Methodology and Associated Outcomes
no summary
Epidemiologic Analysis of Urological Cases Admitted to an Emergency Department of a Tertiary Care Center
Objective: We evaluated emergency urology patients admitted to the emergency department of our hospital in terms of demographic and epidemiological characteristics, in order to contribute to the relevant data of our cou...